EXPL(002096)2021-04-27 16:00Financial Performance - The company's operating revenue for Q1 2021 was ¥405,572,094.49, representing an increase of 11.29% compared to ¥364,417,979.01 in the same period last year[9]. - The net profit attributable to shareholders was -¥17,812,246.82, an improvement of 48.38% from -¥34,507,379.99 year-on-year[9]. - The basic and diluted earnings per share were both -¥0.0480, showing a 4.49% improvement from -¥0.0929 in the same period last year[9]. - The net loss for the current period was ¥17,890,255.47, an improvement from a net loss of ¥34,057,113.22 in the previous period[49]. - The company reported a comprehensive loss of ¥14,766,019.95, compared to a loss of ¥41,415,513.26 in the previous period, indicating a significant reduction in losses[52]. Cash Flow - The net cash flow from operating activities was -¥63,846,470.97, a significant decline of 573.44% compared to ¥13,485,780.15 in the previous year[9]. - Cash flow from operating activities generated a net outflow of -63,846,470.97, compared to a net inflow of 13,485,780.15 in the previous period[60]. - Cash flow from investing activities resulted in a net outflow of -24,096,903.69, compared to -15,244,172.12 in the previous period[62]. - Cash flow from financing activities showed a net outflow of -27,096,262.66, compared to -135,658,395.90 in the previous period[62]. - The net increase in cash and cash equivalents was -122,982,777.72 CNY, slightly improved from -138,267,702.91 CNY in the last period[67]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,875,956,220.27, down 2.75% from ¥3,985,590,615.10 at the end of the previous year[9]. - Total current assets decreased to ¥1,524,647,386.97 from ¥1,642,505,701.23, indicating a decline in liquidity[33]. - Total liabilities decreased from ¥1,909,916,409.22 to ¥1,814,233,929.76, a decrease of about 4.97%[40]. - Current liabilities decreased from ¥1,318,833,553.32 to ¥1,262,936,518.19, a reduction of about 4.24%[38]. - Total equity decreased from ¥2,075,674,205.88 to ¥2,061,722,290.51, a decline of approximately 0.67%[40]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,002[12]. - The largest shareholder, Hunan Nanling Chemical Group Co., Ltd., held 41.62% of the shares, totaling 154,545,912 shares[13]. Expenses - Sales expenses increased by 31.24% to ¥17,569,354.54 from ¥13,387,586.63, mainly due to increased expenditures on new product development[20]. - R&D expenses surged by 90.71% to ¥17,108,549.36 from ¥8,970,906.01, attributed to reduced bank borrowings leading to lower interest expenses[20]. - The total operating costs amounted to ¥425,746,562.14, up from ¥399,836,801.46, reflecting a rise of 6.73%[47]. Government Subsidies - The company received government subsidies totaling ¥4,064,121.89 during the reporting period, which included ¥46,600 in current subsidies and ¥117,500 from previous years[9]. - Other income rose by 160.61% to ¥4,064,121.89 from ¥1,559,470.86, primarily due to an increase in government subsidies received[20]. Future Outlook and Strategy - The first quarter report was not audited, indicating preliminary financial data[76]. - The company has not disclosed any new product developments or market expansion strategies in this report[75]. - There is no mention of future outlook or performance guidance in the provided documents[75]. - The report does not include any information on mergers or acquisitions[75].